Skip to content
RP720

Drawing based on the label description. No photo yet.

RP 720 pill

Pill with imprint RP 720 is orange, capsule, 18 mm and has been identified as Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate 5 mg / 5 mg / 5 mg / 5 mg. It is used for ADHD. It is supplied by Rhodes Pharmaceuticals L.p.

Controlled substance: Schedule II

Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate 5 mg / 5 mg / 5 mg / 5 mg

Imprint
RP 720
Strength
Dextroamphetamine Saccharate 5 mg / Amphetamine Aspartate Monohydrate 5 mg / Dextroamphetamine Sulfate 5 mg / Amphetamine Sulfate 5 mg
Used for
ADHD
Color
Orange
Shape
Capsule / oblong
Size
18 mm
Score
No score line
Form
Capsule, extended release
Manufacturer
Rhodes Pharmaceuticals L.p
Drug class
Stimulant (ADHD medicine)
NDC
42858-720, 42858-720-01

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Dextroamphetamine and Amphetamine and and Amphetamine pills and guides

What is Dextroamphetamine and Amphetamine and and Amphetamine used for?

Dextroamphetamine and Amphetamine and and Amphetamine is used for ADHD.

Medicine type
Stimulant (ADHD medicine)
Official uses from the US prescribing label

Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and Narcolepsy.

Attention Deficit Hyperactivity Disorder (ADHD)

A diagnosis of Attention Deficit Hyperactivity Disorder (ADHD; DSM-IV ®) implies the presence of hyperactive-impulsive or inattentive symptoms that caused impairment and were present before age 7 years. The symptoms must cause clinically significant impairment, e.g., in social, academic, or occupational functioning, and be present in two or more settings, e.g., school (or work) and at home. The symptoms must not be better accounted for by another mental disorder. For the Inattentive Type, at least six of the following symptoms must have persisted for at least 6 months: lack of attention to details/careless mistakes; lack of sustained attention; poor listener; failure to follow through on tasks; poor organization; avoids tasks requiring sustained mental effort; loses things; easily distracted; forgetful. For the Hyperactive-Impulsive Type, at least six of the following symptoms must have persisted for at least 6 months: fidgeting/squirming; leaving seat; inappropriate running/climbing; difficulty with quiet activities; “on the go;” excessive talking; blurting answers; can't wait turn; intrusive. The Combined Type requires both inattentive and hyperactive-impulsive criteria to be met.

Special Diagnostic Considerations

Specific etiology of this syndrome is unknown, and there is no single diagnostic test. Adequate diagnosis requires the use not only of medical but of special psychological, educational, and social resources. Learning may or may not be impaired. The diagnosis must be based upon a complete history and evaluation of the child and not solely on the presence of the required number of DSM-IV ® characteristics.

Need for Comprehensive Treatment Program

Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets are indicated as an integral part of a total treatment program for ADHD that may include other measures (psychological, educational, social) for patients with this syndrome. Drug treatment may not be indicated for all children with this syndrome. Stimulants are not intended for use in the child who exhibits symptoms secondary to environmental factors and/or other primary psychiatric disorders, including psychosis. Appropriate educational placement is essential and psychosocial intervention is often helpful. When remedial measures alone are insufficient, the decision to prescribe stimulant medication will depend upon the physician's assessment of the chronicity and severity of the child's symptoms.

Long-Term Use

The effectiveness of Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets for long-term use has not been systematically evaluated in controlled trials. Therefore, the physician who elects to use Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets for extended periods should periodically re-evaluate the long-term usefulness of the drug for the individual patient.

From the FDA-approved label on DailyMed (published Nov 24, 2025).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows RP 720. The parts can be split between the two sides, so turn the pill over and check both.
  • It is orange, capsule, 18 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold under the brand name Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Extended-Release.

Ingredients

Active: Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate

Inactive: Sucrose, Hypromellose, Unspecified, Talc, Triethyl Citrate, Methacrylic Acid and Ethyl Acrylate Copolymer, Water, Gelatin, Unspecified, Titanium Dioxide, Fd&c Blue No. 1, Fd&c Yellow No. 6, Shellac, Isopropyl Alcohol, Tert-Butyl Alcohol, Propylene Glycol, Ammonia, Ferrosoferric Oxide, Potassium Hydroxide

Also distributed by

Rhodes Pharmaceuticals LLC

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Dextroamphetamine and Amphetamine and and Amphetamine pills